Acusensus Limited reported a robust 40% increase in revenue to $40.3 million for the half-year ended December 2025, driven by new contracts and international growth. However, the company recorded a substantial $20.8 million loss, largely due to a $16 million litigation settlement and strategic investments in future growth.
Omni Bridgeway Limited has reported record investment proceeds of A$555.5 million for FY25, underpinned by robust completions and a growing pipeline. Positive regulatory shifts in key markets further bolster the company’s outlook.